4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-21-044012
President sold 25,000 shares at $156.55 ($3,913,750)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Novak Rodger President | 2021-06-28 | Sale | −25,000 | $156.55 | $3,913,750 | 598,007 | D |
| Open-market sales · 25,000 sh · avg $156.55 · $3,913,750 | |||||||
Loading xslF345X03/doc4.xml…